Skip to main content

Attovia Therapeutics, Inc.

ATTO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002058707

In the last 90 days, Attovia Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 65 institutions reported holding it in 13F filings for Q3 2026, worth $693.4M in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Attovia Therapeutics, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Attovia Therapeutics, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 9, 202610-Q–Sep 30, 2026SECIndex
Nov 9, 20268-K2.028.01Nov 9, 2026SECIndex
Sep 2, 202610-Q–Jun 30, 2026SECIndex
Sep 2, 20268-K2.029.01Sep 2, 2026SECIndex
Aug 6, 20268-K5.039.01Aug 6, 2026SECIndex